Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric
Clinical trial NCT06181695 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06181695
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-02
- Primary completion
- 2026-05-30
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.